Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
about
The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminaseStructure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivHLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseasesEx vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersStructure of a TCR with high affinity for self-antigen reveals basis for escape from negative selectionStructure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityA molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritisSusceptibility to HLA-DM Protein Is Determined by a Dynamic Conformation of Major Histocompatibility Complex Class II Molecule Bound with PeptideT-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsEditing of the HLA-DR-peptide repertoire by HLA-DMRemoving T-cell epitopes with computational protein design.Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targetsT-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.Peptide vaccines and peptide libraries.Variations in the electrostatic landscape of class II human leukocyte antigen molecule induced by modifications in the myelin basic protein peptide: a theoretical approach.Correlated evolution of nucleotide substitution rates and allelic variation in Mhc-DRB lineages of primates.Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.Peptide-based molecular analyses of HLA class II-associated susceptibility to autoimmune diseases.Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.High-throughput engineering and analysis of peptide binding to class II MHCMolecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity.MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris.Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.Synthetic peptide vaccines effective in preventing virus infection.Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) regionVaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoproteinMHCPEP: a database of MHC-binding peptides.Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.Binding interactions between peptides and proteins of the class II major histocompatibility complex.Identification and characterization of novel, naturally processed measles virus class II HLA-DRB1 peptides.Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation studyTumor-specific shared antigenic peptides recognized by human T cells.PAComplex: a web server to infer peptide antigen families and binding models from TCR-pMHC complexes.High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinationsT-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/IIDivergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.Polyspecificity of T cell and B cell receptor recognition.
P2860
Q24671041-ECA4826F-8988-4485-9030-BA55BD1AC813Q24673986-F2CC6F9C-AF40-4B0D-BDB9-721B4B00470DQ24679388-204583D9-CF07-4076-A078-F54EBAB59397Q27480953-0C256522-792E-467E-99A8-FB58C8302202Q27666863-E377C9A1-F7B6-445F-B4FD-DAAC757B1665Q27680213-DCFF1B41-047D-4979-943B-BF189B334866Q27680522-4D1AF2B8-22C4-40BC-B94D-DAFB593D4D21Q27684590-C45C2BC1-7AD4-4F99-8D8B-126465637AA1Q28485408-B07169C9-DB03-4F7F-85EE-0F0C3FC5173EQ28613148-958A4552-A710-4C04-8FA3-5B4477DA6401Q30362724-F722E6A0-EBEE-4F31-B70D-FDA92C6D4AC0Q30366017-0F6F04D8-FA47-46B1-A363-CD53ACB8331DQ30620098-114DAC0C-9E21-4338-84A4-24CE59A9D1DDQ30992372-97FCAAB2-36B9-48EB-B0EB-B967E6F4E5F0Q33398539-B5183D8B-48F6-4CFC-B6E4-09C1F2485897Q33429263-A58773DA-505F-42BC-B468-0B0D0962006DQ33530024-9311C2BF-35C1-4CCD-9497-F9BFD044C3D7Q33536183-B29D5C43-FE79-45A9-B564-53B38605992CQ33575103-FEDA714B-EE1A-49EA-9059-284977D9E783Q33630225-51098A7E-E530-467D-8526-94DBC8A17412Q33630981-EF03A0CF-3E48-4254-835A-DE914CCD0DA0Q33702755-BA38B6FA-1F39-4162-8C82-000DA2C902E9Q33734713-BF8F873B-D971-446A-92AB-3AFE8EDCECB4Q33757364-88161791-FD9E-4544-99BB-2BDA6A7588A4Q33786753-AEE37904-12D9-469C-B90F-47657F874CC5Q33887531-7879BFED-3062-4CD9-BCE8-99A4FB612C06Q34105207-84665D0B-E560-4393-BAA0-FDA1DADCDB3CQ34125960-77EAA74E-B09F-4F8C-93BF-2FFA09B1E06EQ34261503-5236EC02-5E20-400A-95E1-AC0912A8D596Q34324209-201EAEC8-0032-40F3-94FB-28A0EB7A519DQ34370060-7D8533F1-F9A8-4BCF-A917-E59C5A5B07AEQ34540061-CE6AB8E4-7154-4622-B621-7ED28CC07A43Q34554618-7785343F-EEB7-4B2E-BCA3-E395714B27F3Q34651994-29B86A1F-B567-45B1-AC8B-66EC150793A6Q35005926-42C22385-A765-4FF6-ABE6-58EA7AB98358Q35075684-954A4C36-37B2-4809-BAD1-91952C4D1986Q35235094-EADEAD57-0143-4C3A-8716-1724DE9ABE9FQ35439121-824752ED-46B7-470D-B459-0B928EAED231Q35839141-CBF4C605-2CD8-4989-AF5E-42A92F41BF35Q36082439-58CCB483-5541-4041-929A-B838AE17B0E7
P2860
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@ast
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@en
type
label
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@ast
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@en
prefLabel
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@ast
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@en
P2093
P1433
P1476
Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
@en
P2093
Sinigaglia F
Valsasnini P
P304
P356
10.1016/0092-8674(93)90306-B
P407
P577
1993-07-01T00:00:00Z